대한민국 당뇨병 약물 시장 보고서약물별(인슐린, 경구용 항당뇨제, 비인슐린 주사제, 복합제), 유통 채널별(온라인 약국, 병원 약국, 소매 약국), 지역별 2025-2033

대한민국 당뇨병 약물 시장 보고서약물별(인슐린, 경구용 항당뇨제, 비인슐린 주사제, 복합제), 유통 채널별(온라인 약국, 병원 약국, 소매 약국), 지역별 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A35901

Language of the Report – English

하지만 추가 비용을 지불하시면 보고서를 한국어로 제공해 드릴 수 있습니다.

1   Preface 
2   Scope and Methodology 

    2.1    Objectives of the Study 
    2.2    Stakeholders 
    2.3    Data Sources 
        2.3.1    Primary Sources 
        2.3.2    Secondary Sources 
    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach 
        2.4.2    Top-Down Approach 
    2.5    Forecasting Methodology 
3   Executive Summary 
4   South Korea Diabetes Drugs Market - Introduction 

    4.1    Overview 
    4.2    Market Dynamics 
    4.3    Industry Trends 
    4.4    Competitive Intelligence 
5   South Korea Diabetes Drugs Market Landscape 
    5.1    Historical and Current Market Trends (2019-2024) 
    5.2    Market Forecast (2025-2033)
6   South Korea Diabetes Drugs Market - Breakup by Drugs 
    6.1    Insulins
        6.1.1 Overview 
        6.1.2 Historical and Current Market Trends (2019-2024)
        6.1.3 Market Segmentation
           6.1.3.1 Basal or Long Acting Insulins
           6.1.3.2 Bolus or Fast Acting Insulins
           6.1.3.3 Traditional Human Insulins
           6.1.3.4 Biosimilar Insulins
        6.1.4 Market Forecast (2025-2033) 
    6.2    Oral Anti-diabetic Drugs
        6.2.1 Overview 
        6.2.2 Historical and Current Market Trends (2019-2024) 
        6.2.3 Market Segmentation
           6.2.3.1 Biguanides
           6.2.3.2 Alpha-Glucosidase Inhibitors
           6.2.3.3 Dopamine D2 Receptor Agonist
           6.2.3.4 SGLT-2 Inhibitors
           6.2.3.5 DPP-4 Inhibitors
           6.2.3.6 Sulfonylureas
           6.2.3.7 Meglitinides
        6.2.4 Market Forecast (2025-2033) 
    6.3    Non-Insulin Injectable Drugs
        6.3.1 Overview 
        6.3.2 Historical and Current Market Trends (2019-2024) 
        6.3.3 Market Segmentation
           6.3.3.1 GLP-1 Receptor Agonists
           6.3.3.2 Amylin Analogue
        6.3.4 Market Forecast (2025-2033) 
    6.4    Combination Drugs
        6.4.1 Overview 
        6.4.2 Historical and Current Market Trends (2019-2024) 
        6.4.3 Market Segmentation
           6.4.3.1 Insulin Combinations
           6.4.3.2 Oral Combinations
        6.4.4 Market Forecast (2025-2033) 
7   South Korea Diabetes Drugs Market - Breakup by Distribution Channel  
    7.1    Online Pharmacies
        7.1.1 Overview 
        7.1.2 Historical and Current Market Trends (2019-2024) 
        7.1.3 Market Forecast (2025-2033) 
    7.2    Hospital Pharmacies
        7.2.1 Overview 
        7.2.2 Historical and Current Market Trends (2019-2024) 
        7.2.3 Market Forecast (2025-2033) 
    7.3    Retail Pharmacies
        7.3.1 Overview 
        7.3.2 Historical and Current Market Trends (2019-2024) 
        7.3.3 Market Forecast (2025-2033) 
8   South Korea Diabetes Drugs Market – Breakup by Region
    8.1    Seoul Capital Area
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2019-2024)
        8.1.3 Market Breakup by Drugs
        8.1.4 Market Breakup by Distribution Channel
        8.1.5 Key Players
        8.1.6 Market Forecast (2025-2033)
    8.2    Yeongnam (Southeastern Region)
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2019-2024)
        8.2.3 Market Breakup by Drugs
        8.2.4 Market Breakup by Distribution Channel
        8.2.5 Key Players
        8.2.6 Market Forecast (2025-2033)
    8.3    Honam (Southwestern Region)
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (2019-2024)
        8.3.3 Market Breakup by Drugs
        8.3.4 Market Breakup by Distribution Channel
        8.3.5 Key Players
        8.3.6 Market Forecast (2025-2033) 
    8.4    Hoseo (Central Region)
        8.4.1 Overview
        8.4.2 Historical and Current Market Trends (2019-2024)
        8.4.3 Market Breakup by Drugs
        8.4.4 Market Breakup by Distribution Channel
        8.4.5 Key Players
        8.4.6 Market Forecast (2025-2033)
    8.5    Others
        8.5.1 Historical and Current Market Trends (2019-2024)
        8.5.2 Market Forecast (2025-2033)
9   South Korea Diabetes Drugs Market – Competitive Landscape 
    9.1    Overview 
    9.2    Market Structure 
    9.3    Market Player Positioning 
    9.4    Top Winning Strategies 
    9.5    Competitive Dashboard 
    9.6    Company Evaluation Quadrant 
10   Profiles of Key Players 
    10.1    Company A  
        10.1.1 Business Overview 
        10.1.2 Product Portfolio 
        10.1.3 Business Strategies 
        10.1.4 SWOT Analysis 
        10.1.5 Major News and Events 
    10.2    Company B 
        10.2.1 Business Overview 
        10.2.2 Product Portfolio 
        10.2.3 Business Strategies 
        10.2.4 SWOT Analysis 
        10.2.5 Major News and Events 
    10.3    Company C 
        10.3.1 Business Overview 
        10.3.2 Product Portfolio 
        10.3.3 Business Strategies 
        10.3.4 SWOT Analysis 
        10.3.5 Major News and Events 
    10.4    Company D  
        10.4.1 Business Overview 
        10.4.2 Product Portfolio 
        10.4.3 Business Strategies 
        10.4.4 SWOT Analysis 
        10.4.5 Major News and Events 
    10.5    Company E 
        10.5.1 Business Overview 
        10.5.2 Product Portfolio 
        10.5.3 Business Strategies 
        10.5.4 SWOT Analysis 
        10.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report. 
 
11   South Korea Diabetes Drugs Market - Industry Analysis 

    11.1    Drivers, Restraints, and Opportunities 
        11.1.1 Overview 
        11.1.2 Drivers 
        11.1.3 Restraints 
        11.1.4 Opportunities 
    11.2   Porters Five Forces Analysis 
        11.2.1 Overview 
        11.2.2 Bargaining Power of Buyers 
        11.2.3 Bargaining Power of Suppliers 
        11.2.4 Degree of Competition 
        11.2.5 Threat of New Entrants 
        11.2.6 Threat of Substitutes 
    11.3    Value Chain Analysis 
12   Appendix

대한민국 당뇨병 약물 시장 보고서약물별(인슐린, 경구용 항당뇨제, 비인슐린 주사제, 복합제), 유통 채널별(온라인 약국, 병원 약국, 소매 약국), 지역별 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials